On Feb. 10, a panel of drug safety experts unexpectedly recommended that the U.S. Food and Drug Administration put a visible, boxed warning on stimulant medicines like Adderall, Ritalin and Concerta, which are used to treat the disorder in both children and adults.

FORBES: Pay Attention

Lilly has another promising brain drug nearing the end of its development as well: Strattera, a non-stimulant treatment for attention-deficit disorder.

FORBES: Eli Lilly Goes Back To The Brain